|
|
 |
|
Viewing report
|
|
|
|
Global In Vitro Diagnostics Market 2010-2014
Infiniti Research Limited, Nov 2011, Pages: 32
TechNavio’s analysts forecast the Global In Vitro Diagnostics market to grow at a CAGR of six percent over the period 2010–2014. One of the key factors contributing to this market growth is increased demand for biomarker-based tests. The Global In Vitro Diagnostics market has also been witnessing significant growth of point-of-care (POC) cardiac markers. However, the slow growth of clinical assays could pose a challenge to the growth of this market. TechNavio’s report, Global In Vitro Diagnostics Market 2010–2014, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions. It covers In Vitro Diagnostics products, medical reagents, and assays that are used for the diagnosis of healthcare patients worldwide. It analyzes the current Global In Vitro Diagnostics market landscape and its growth prospects. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market include Hoffmann-La Roche Ltd., Siemens Healthcare, Veridex LLC, Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson, and bioMerieux.
Key questions answered in this report:
What will the market size be in 2014 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
|
|
|
|
